Ovagen 20mg
Liver and GI Peptide Bioregulator for Digestive System Research
Ovagen is a Khavinson tetrapeptide bioregulator targeting liver and gastrointestinal tissue, supporting digestive organ gene expression normalization and healing in research models.
Liver and GI Peptide Bioregulator for Digestive System Research
GI and hepatic tissue-specific peptide bioregulator supporting liver and gut epithelial cell function through epigenetic gene expression modulation.
As one of the most studied compounds in the recovery & healing research space, Ovagen has attracted sustained scientific interest across GI tissue research, Hepatic and digestive system studies. Peer-reviewed evidence indicates that gI-hepatic Khavinson bioregulator, which has positioned Ovagen as a reference standard for researchers exploring gi tissue research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Ovagen Documented Benefits: 1 Documented Mechanisms
GI Tissue Support
Normalizes gene expression in liver and GI epithelial cells for digestive organ health.
How Ovagen Works: Molecular Mechanism & Pathway
Short peptide with GI and hepatic tissue specificity for epigenetic gene expression modulation.
The 1 primary research pathways identified for Ovagen — GI Tissue Support — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that digestive tissue gene expression normalization, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Ovagen's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Ovagen is routinely studied alongside BPC-157 and KPV in recovery & healing-focused compound panels. Researchers investigating gi tissue research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that 20mg format has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Ovagen research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- GI-hepatic Khavinson bioregulator
- Digestive tissue gene expression normalization
- 20mg format
Ideal For
- GI tissue research
- Hepatic and digestive system studies
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Ovagen. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
GI-hepatic Khavinson bioregulator
Digestive tissue gene expression normalization
20mg format
Third-Party Verified Every Batch
Each vial of Ovagen is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
